Tefera Agizew

800 total citations
23 papers, 534 citations indexed

About

Tefera Agizew is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Tefera Agizew has authored 23 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 17 papers in Epidemiology and 7 papers in Surgery. Recurrent topics in Tefera Agizew's work include Tuberculosis Research and Epidemiology (20 papers), Pneumocystis jirovecii pneumonia detection and treatment (10 papers) and Diagnosis and treatment of tuberculosis (5 papers). Tefera Agizew is often cited by papers focused on Tuberculosis Research and Epidemiology (20 papers), Pneumocystis jirovecii pneumonia detection and treatment (10 papers) and Diagnosis and treatment of tuberculosis (5 papers). Tefera Agizew collaborates with scholars based in Botswana, United States and South Africa. Tefera Agizew's co-authors include Zegabriel Tedla, Taraz Samandari, Samba Nyirenda, Oaitse I. Motsamai, Charles D. Wells, Barudi Mosimaneotsile, Peter H. Kilmarx, Nong Shang, Lorna Bozeman and Howard Moffat and has published in prestigious journals such as The Lancet, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Tefera Agizew

23 papers receiving 525 citations

Peers

Countries citing papers authored by Tefera Agizew

Since Specialization

Citations

This map shows the geographic impact of Tefera Agizew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tefera Agizew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tefera Agizew more than expected).

Fields of papers citing papers by Tefera Agizew

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tefera Agizew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tefera Agizew. The network helps show where Tefera Agizew may publish in the future.

Co-authorship network of co-authors of Tefera Agizew

This figure shows the co-authorship network connecting the top 25 collaborators of Tefera Agizew. A scholar is included among the top collaborators of Tefera Agizew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tefera Agizew. Tefera Agizew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Increased tuberculosis case detection in Tanzanian children and adults using African giant pouched rats 2024 ·BMC Infectious Diseases ·Tefera Agizew, (unknown), Cynthia D. Fast, (unknown), (unknown), N Edward, (unknown), (unknown), (unknown), Christophe Cox, Negussie Beyene	1
2	Prospects for tuberculosis elimination in Ethiopia: feasibility, challenges, and opportunities 2022 ·Pan African Medical Journal ·Tefera Agizew, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Pedro Suarez, (unknown), (unknown), (unknown), Degu Jerene	10
3	Tuberculosis preventive treatment opportunities at antiretroviral therapy initiation and follow-up visits 2020 ·Public Health Action ·Tefera Agizew, Diya Surie, John E. Oeltmann, (unknown), Steven T. Pals, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Andrew F. Auld, Alyssa Finlay	1
4	Improving sputum collection processes to increase tuberculosis case finding among HIV-positive persons in Botswana 2020 ·Public Health Action ·(unknown), (unknown), Tefera Agizew, Steven T. Pals, (unknown), (unknown), (unknown), (unknown), (unknown), Anand Date, Andrew F. Auld, Alyssa Finlay	6
5	Contribution of Xpert ^® MTB/RIF to tuberculosis case finding among pregnant women in Botswana 2020 ·Public Health Action ·(unknown), (unknown), Dipesalema Joel, (unknown), (unknown), (unknown), (unknown), (unknown), Tefera Agizew	3
6	Outcomes of HIV-positive patients with non-tuberculous mycobacteria positive culture who received anti-tuberculous treatment in Botswana: Implications of using diagnostic algorithms without non-tuberculous mycobacteria 2020 ·PLoS ONE ·Tefera Agizew, (unknown), (unknown), (unknown), (unknown), (unknown), Sherri Pals, Alyssa Finlay, Phenyo Lekone, (unknown), (unknown), Violet Chihota, Andrew F. Auld	3
7	Effect of tuberculosis screening and retention interventions on early antiretroviral therapy mortality in Botswana: a stepped-wedge cluster randomized trial 2020 ·BMC Medicine ·Andrew F. Auld, Tefera Agizew, (unknown), (unknown), Anand Date, Sherri Pals, (unknown), (unknown), Heather Alexander, Tedd V. Ellerbrock, (unknown), (unknown), James C. Shepherd, Katherine Fielding, Alison D. Grant, Alyssa Finlay	4
8	Treatment outcomes, diagnostic and therapeutic impact: Xpert vs. smear. A systematic review and meta-analysis 2019 ·The International Journal of Tuberculosis and Lung Disease ·Tefera Agizew, Roslyn N. Boyd, Andrew F. Auld, (unknown), Sherri Pals, Phenyo Lekone, Violet Chihota, Andrea K. Finlay	17
9	Tuberculosis treatment outcomes among people living with HIV diagnosed using Xpert MTB/RIF versus sputum-smear microscopy in Botswana: a stepped-wedge cluster randomised trial 2019 ·BMC Infectious Diseases ·Tefera Agizew, Violet Chihota, (unknown), Zegabriel Tedla, Andrew F. Auld, (unknown), (unknown), (unknown), Anand Date, Sherri Pals, Phenyo Lekone, Alyssa Finlay	6
10	The effect of sputum quality and volume on the yield of bacteriologically-confirmed TB by Xpert MTB/RIF and smear 2019 ·Pan African Medical Journal ·(unknown), Tsaone Tamuhla, (unknown), (unknown), Sherri Pals, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Alyssa Finlay, Andrew F. Auld, Anand Date, Heather Alexander, Violet Chihota, Tefera Agizew	7
11	Peripheral clinic versus centralized laboratory-based Xpert MTB/RIF performance: Experience gained from a pragmatic, stepped-wedge trial in Botswana 2017 ·PLoS ONE ·Tefera Agizew, (unknown), Ndwapi Ndwapi, Andrew F. Auld, (unknown), (unknown), Zegabriel Tedla, (unknown), (unknown), (unknown), Sherri Pals, Anand Date, Heather Alexander, (unknown), Alyssa Finlay	16
12	Higher-than-expected prevalence of non-tuberculous mycobacteria in HIV setting in Botswana: Implications for diagnostic algorithms using Xpert MTB/RIF assay 2017 ·PLoS ONE ·Tefera Agizew, (unknown), Heather Alexander, (unknown), (unknown), Andrew F. Auld, (unknown), Zegabriel Tedla, (unknown), (unknown), Sherri Pals, Anand Date, Alyssa Finlay	28
13	Implementation of a pragmatic, stepped-wedge cluster randomized trial to evaluate impact of Botswana’s Xpert MTB/RIF diagnostic algorithm on TB diagnostic sensitivity and early antiretroviral therapy mortality 2016 ·BMC Infectious Diseases ·Andrew F. Auld, Tefera Agizew, Sherri Pals, Alyssa Finlay, Ndwapi Ndwapi, (unknown), Heather Alexander, (unknown), (unknown), (unknown), James Shepherd, Tedd V. Ellerbrock, Anand Date	12
14	Tuberculosis incidence after 36 months’ isoniazid prophylaxis in HIV-infected adults in Botswana 2014 ·AIDS ·Taraz Samandari, Tefera Agizew, Samba Nyirenda, Zegabriel Tedla, (unknown), Barudi Mosimaneotsile, Oaitse I. Motsamai, Nong Shang, Charles E. Rose, James Shepherd	33
15	Isoniazid-Associated Hepatitis in Adults Infected With HIV Receiving 36 Months of Isoniazid Prophylaxis in Botswana 2014 ·CHEST Journal ·Zegabriel Tedla, (unknown), (unknown), Samba Nyirenda, Tefera Agizew, (unknown), Charles E. Rose, Taraz Samandari	8
16	6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial 2011 ·The Lancet ·Taraz Samandari, Tefera Agizew, Samba Nyirenda, Zegabriel Tedla, (unknown), Nong Shang, Barudi Mosimaneotsile, Oaitse I. Motsamai, Lorna Bozeman, Margarett K. Davis, Elizabeth A. Talbot, Themba Moeti, Howard Moffat, Peter H. Kilmarx, Kenneth G. Castro, Charles D. Wells	258
17	Tuberculosis in asymptomatic HIV-infected adults with abnormal chest radiographs screened for tuberculosis prevention. 2010 ·PubMed ·Tefera Agizew, M. Allison Arwady, (unknown), Samba Nyirenda, Barudi Mosimaneotsile, Zegabriel Tedla, Oaitse I. Motsamai, Peter H. Kilmarx, Charles D. Wells, Taraz Samandari	14
18	Association of chest radiographic abnormalities with tuberculosis disease in asymptomatic HIV-infected adults. 2010 ·PubMed ·Tefera Agizew, Marcus A. Bachhuber, Samba Nyirenda, (unknown), Zegabriel Tedla, (unknown), J. E. S. Parker, (unknown), Taraz Samandari	17
19	Isoniazid-associated Hepatitis and Antiretroviral Drugs during Tuberculosis Prophylaxis in HIV-infected Adults in Botswana 2010 ·American Journal of Respiratory and Critical Care Medicine ·Zegabriel Tedla, Samba Nyirenda, Crandall E. Peeler, Tefera Agizew, (unknown), Oaitse I. Motsamai, Andrew Vernon, Charles D. Wells, Taraz Samandari	37
20	Isoniazid Tuberculosis Preventive Therapy in HIV-Infected Adults Accessing Antiretroviral Therapy: A Botswana Experience, 2004-2006 2010 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Barudi Mosimaneotsile, (unknown), (unknown), Samba Nyirenda, Tefera Agizew, Zegabriel Tedla, Oaitse I. Motsamai, Peter H. Kilmarx, Charles D. Wells, Taraz Samandari	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact